Company Search:
Advanced Search
Sponsored Links
ExpreS2ion Biotech Holding AB Company Snapshot
ExpreS2ion Biotech Holding AB operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares ExpreS2ion Biotech Holding AB with three other pharmaceutical manufacturers in Europe: Futura Medical PLC of the United Kingdom (2017 sales of £362,727.00 [US$505,895.35 ] ), Oncimmune Holdings PLC of the United Kingdom (£215,000.00 [US$299,860.50 ] of which 100% was Distribution of testing products), and Angle PLC which is also based in the United Kingdom (£498,000.00 [US$694,560.60 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ExpreS2ion Biotech Holding AB
  Stock Performance Chart for ExpreS2ion Biotech Holding AB
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 10.20
(Figures in Swedish Kronor)
1 Week -0.5%   13 Weeks 2.8%  
4 Weeks -3.4%   52 Weeks 77.0%  
ExpreS2ion Biotech Holding AB Key Data:
  Ticker: EXPRS2 Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 9,795,000
(Year Ending Jan 2018).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 101,055,730
  Fiscal Yr Ends: December Shares Outstanding: 9,907,424
  Share Type: Aktie Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.